LGALS3 and hydrops fetalis: This result is in concordance with a study conducted by Lebedev et al. in 2020 [55] that stated a medium Gal-3 value of 11.7ng/mL and 10.4ng/mL in patients with HFPEF/HFmEF and T2DM and were significantly higher comparative to T2DM patients without HF in whom the value of Gal-3 was 8.6 ng/mL (p < 0.05) [55].